tetano
Editor, Senior Moderator
Cureus
. 2021 Jan 20;13(1):e12796.
doi: 10.7759/cureus.12796.
Right Ovarian Vein Thrombosis in the Setting of COVID-19 Infection
Rebecca E DeBoer[SUP] 1 [/SUP], Olubunmi O Oladunjoye[SUP] 1 [/SUP], Ronald Herb[SUP] 1 [/SUP]
Affiliations
Abstract
Ovarian vein thrombosis is a rare condition associated with the postpartum state, pelvic disease, gynecological surgeries, and other thrombophilic states. We present the first reported case of right ovarian vein thrombosis (OVT) in the setting of Coronavirus disease 2019 (COVID-19) unrelated to pregnancy, pelvic disease, or surgery. This case highlights the breadth of the hypercoagulable state induced by COVID-19. We also put forward the use of novel oral anticoagulants in the case of OVT.
Keywords: covid-19; hypercoagulable state; novel oral anticoagulant; ovarian vein thrombosis.
. 2021 Jan 20;13(1):e12796.
doi: 10.7759/cureus.12796.
Right Ovarian Vein Thrombosis in the Setting of COVID-19 Infection
Rebecca E DeBoer[SUP] 1 [/SUP], Olubunmi O Oladunjoye[SUP] 1 [/SUP], Ronald Herb[SUP] 1 [/SUP]
Affiliations
- PMID: 33628665
- PMCID: PMC7893676
- DOI: 10.7759/cureus.12796
Abstract
Ovarian vein thrombosis is a rare condition associated with the postpartum state, pelvic disease, gynecological surgeries, and other thrombophilic states. We present the first reported case of right ovarian vein thrombosis (OVT) in the setting of Coronavirus disease 2019 (COVID-19) unrelated to pregnancy, pelvic disease, or surgery. This case highlights the breadth of the hypercoagulable state induced by COVID-19. We also put forward the use of novel oral anticoagulants in the case of OVT.
Keywords: covid-19; hypercoagulable state; novel oral anticoagulant; ovarian vein thrombosis.